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Sarcoidosis is a multisystemic disorder of unknown aetiology characterised by the formation of noncaseating epithelioid cell
granuloma involving various organ systems. Cardiac involvement has an important prognostic factor as it can present with life-
threatening arrythmias and sudden death. Here, we present a case of cardiac sarcoidosis in a 46-year-old gentleman who presented
withnonspeciﬁcsignsandsymptoms.Wealsodiscussdiagnosticdiﬃcultiesespeciallywhencardiacinvolvementistheonlyclinical
sign. In this case, cardiac magnetic resonance (CMR) played an important role in the diagnosis and followup of our patient.
1.Introduction
Cardiacsarcoidosisisanimportantcauseofdeathinpatients
withsystemicsarcoidosis.Approximately20–30%ofpatients
with systemic sarcoidosis have evidence of granulomatous
inﬁltration of the myocardium at autopsy [1]. The presence
of scar tissue in the myocardium increases the risk of malig-
nant arrhythmias, and up to 60% of fatalities from cardiac
sarcoidosis present as sudden cardiac death [2].
2. Case Presentation
A previously well forty-six-year old Caucasian man present-
ed with exertional dyspnoea and two cutaneous nodules on
his left wrist which were biopsied and conﬁrmed as sarcoid
nodules.
He was referred to the respiratory physicians for further
investigations. Chest X-ray showed classical changes of pul-
monary sarcoidosis, and serum ACE was mildly elevated at
92U/L.Healsodescribedepisodesofpalpitationonexertion,
ankle oedema, and progressively worsening breathlessness.
However, the extent of his dyspnoea seemed disproportion-
ate to that of his pulmonary involvement. An electrocardi-
ogram (ECG) showed sinus rhythm with a prolonged PR in-
terval (210 milliseconds), right bundle branch block, and left
anterior fascicular block.
Based on his clinical presentation and ECG abnormali-
ties, heart failure secondary to cardiac sarcoidosis was sus-
pected and he was referred to the cardiology department.
Twenty-four-hour ambulatory monitoring showed sinus
rhythm though out with short runs of sinus tachycardia. Se-
rumbrain-natriureticpeptide(BNP)levelwasunremarkable
at 21.3pg/mL (normally less than 50pg/mL). Percutaneous
coronary angiography demonstrated normal coronary arter-
ies,andendomyocardialbiopsyshowed“mild”and“nonspe-
ciﬁc changes,” failing to conﬁrm sarcoid inﬁltration.
A CMR scan was subsequently performed to further ex-
amine the LV systolic function and assess for myocardial sar-
coid inﬁltration. The left ventricle (LV) was nondilated and
demonstrated moderate impairment of LV systolic function
(ejection fraction 39%) associated with an akinetic but non-
thinned interventricular septum. The right ventricular sys-
tolic function was also signiﬁcantly impaired. Late gadolin-
ium enhancement imaging showed several areas of myocar-
dial hyperenhancement involving the anteroseptal subendo-
cardium, subepicardium, and basal lateral epicardium.
The patient was initially treated with high-dose oral pre-
dnisolone therapy (40mg/day) and referred to the tertiary
heart failure centre. Following treatment, twelve lead ECG
abnormalities improved with the only residual abnormality
being right bundle branch block.2 Case Reports in Radiology
Figure 1: Gadolinium contrast-enhanced CMR scan; basal short-
axis view demonstrating areas of hyperenhancement (arrows).
A second CMR scan was carried out 42 days after the
initiation of his steroid therapy and showed marked im-
provement in right and left ventricular systolic function. De-
spite this, the areas of hyperenhancement seen in the ﬁrst
CMR scan remained. In addition, the RV surface of the infe-
rior interventricular septum and RV free wall also appeared
aﬀected (Figure 1).
3. Discussion
Cardiacsarcoidosisisanimportantcauseofdeathinpatients
with systemic sarcoidosis and should be considered in those
who demonstrate cardiac symptoms and/or signs. Myocar-
dial involvement is present in approximately 5 percent of
patients with sarcoidosis although autopsy studies indicate
subclinical cardiac involvement in 20 to 30 percent of cases
[1]. Clinical manifestations of cardiac sarcoidosis depend on
the location and extent of granulomatous inﬁltration and
includeconductionabnormalities,ventricularandsupraven-
tricular arrythmias, heart failure, valvular dysfunction, sim-
ulated infarction, and cor pulmonale.
Signs and symptoms of cardiac sarcoidosis are largely
nonspeciﬁc, and, when cardiac involvement is the sole man-
ifestation, diagnosis is often challenging. Previous attempts
to identify sarcoid inﬁltration of the myocardium relied on
transthoracic echocardiography, nuclear scintigraphy, and
right ventricular endomyocardial biopsy [3]. The features of
sarcoidosis on echocardiography include regional wall mo-
tion abnormalities which are nonspeciﬁc and often not man-
ifest.Nuclearscintigraphyisalsopoorlysensitiveandspeciﬁc
due to its suboptimal spatial resolution and artefacts whilst
biopsy, when positive, is speciﬁc but provides unsatisfactory
yield due to the patchy nature of inﬁltration [4].
CMR is a powerful noninvasive imaging modality which
produces images with excellent spatial, soft tissue, and tem-
poral resolution. Myocardial inﬁltration and scarring can be
observed as late gadolinium hyperenhancement in the mid-
wall and subepicardium. There seems to be a predilection for
thelesionstoaﬀecttheanterobasilar,anterolateralandlateral
wall of the left ventricle. Furthermore, cardiac sarcoidosis is
known to produce zones of thinning, segmental myocardial
wall motion abnormalities, and subendocardial late gadolin-
ium hyperenhancement similar to those seen in myocardial
infarction but often in a noncoronary distribution [5–7].
CMR can be used to guide myocardial biopsy and improve
its sensitivity and in certain cases may obliviate the need for
biopsy completely.
In our patient, the ﬁrst CMR scan demonstrated systolic
dysfunction of both ventricles and both subepicardial and
subendocardial late gadolinium hyperenhancement of the
basal anteroseptal and basal anterolateral regions. This pat-
tern appeared inconsistent with an ischaemic insult to the
myocardium especially in the context of a normal coronary
angiogram. Instead, supported by the normalisation of ven-
tricular function following high-dose prednisolone, we felt
it reﬂected myocardial inﬁltration and scarring secondary to
sarcoidosis.
This case highlights the importance of considering car-
diac sarcoidosis in patients with systemic sarcoidosis when
they present with symptoms such as heart failure. ECG may
also be useful in indicating the possibility of myocardial in-
ﬁltration. CMR oﬀers a powerful noninvasive method of as-
sessingmyocardialﬁbrosisandinﬁltration,whichcangreatly
assist in the diagnosis of sarcoid and in some cases eliminate
the need for biopsy. In our patient, we demonstrated the role
of CMR in diagnosing cardiac sarcoidosis especially when
other investigations including endomyocardial biopsy failed
to conﬁrm sarcoid inﬁltration.
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